Here are relevant reports on : welding-consumables-market
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2030
The global Tissue Diagnostics market, valued at USD 6.19 billion in 2024, stood at USD 6.74 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of USD10.86 billion by the end of the period. The market growth is driven by the rising incidence of cancer and the growing demand for digital pathology, which are fueling the need for more accurate and high-throughput tissue-based diagnostics.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030
The global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030
The global cell culture market, valued at USD 27.92 billion in 2024, stood at USD 29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of USD 50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
High Throughput Process Development Market by Product (Consumables (Minicolumn, Mini Bioreactor), Instruments), Services, Software, Molecule Type (mAB), Technology (Affinity Chromatography), End User (Biopharmaceutical) - Global Forecast to 2021
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 212.1 Million in 2016, at a CAGR of 14.4% from 2016 to 2021. Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Medical Device Manufacturing Equipment (by Production) Market by Type (Material Processing, Sterilization & Cleaning Equipment), Application (Consumables & Disposables), End User (OEMs, Contract Manufacturing Organizations) - Global Forecast to 2030
The global medical device manufacturing equipment (by production) market, valued at US$18.0 billion in 2024, stood at US$19.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$27.80 billion by the end of the period. The medical device manufacturing equipment (by production) market is driven by advancements in automation, robotics, and precision machining, along with increasing demand for high-quality, regulatory-compliant devices.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Hyperbaric Oxygen Therapy Equipment Market by Product (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User - Global Forecast to 2022
The global hyperbaric oxygen therapy equipment market is expected to reach $3.21 Billion by 2022 from $2.26 Billion in 2017, growing at a CAGR of 7.1% from 2017 to 2022. Rising incidence and prevalence of acute and chronic wounds, ready availability of hyperbaric oxygen therapy systems, and growing popularity of leisure and adventure activities are some of the major driving factors driving the growth of the global hyperbaric oxygen therapy equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033
The global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Multiplex Assays Market by Product & Service (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein), Technology (Flow Cytometry, Luminescence), Application (R&D, Diagnosis), End User (Pharma, Hospitals) - Global Forecast to 2027
The global multiplex assays market, valued at US$3.2 billion in 2021, stood at US$3.5 billion in 2022 and is projected to advance at a resilient CAGR of 8.8% from 2022 to 2027, culminating in a forecasted valuation of US$5.3 billion by the end of the period. This provides opportunities for the adoption of multiplex assays, with their potential for automation, convenience, accuracy, and reproducibility.
- Published: April 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
